Literature DB >> 22562654

Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.

Melyssa R Bratton1, James W Antoon, Bich N Duong, Daniel E Frigo, Syreeta Tilghman, Bridgette M Collins-Burow, Steven Elliott, Yan Tang, Lilia I Melnik, Ling Lai, Jawed Alam, Barbara S Beckman, Steven M Hill, Brian G Rowan, John A McLachlan, Matthew E Burow.   

Abstract

The estrogen receptor α (ERα) is a transcription factor that mediates the biological effects of 17β-estradiol (E(2)). ERα transcriptional activity is also regulated by cytoplasmic signaling cascades. Here, several Gα protein subunits were tested for their ability to regulate ERα activity. Reporter assays revealed that overexpression of a constitutively active Gα(o) protein subunit potentiated ERα activity in the absence and presence of E(2). Transient transfection of the human breast cancer cell line MCF-7 showed that Gα(o) augments the transcription of several ERα-regulated genes. Western blots of HEK293T cells transfected with ER±Gα(o) revealed that Gα(o) stimulated phosphorylation of ERK 1/2 and subsequently increased the phosphorylation of ERα on serine 118. In summary, our results show that Gα(o), through activation of the MAPK pathway, plays a role in the regulation of ERα activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562654      PMCID: PMC3614348          DOI: 10.1530/JOE-12-0097

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  78 in total

1.  A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I.

Authors:  M B Martin; T F Franke; G E Stoica; P Chambon; B S Katzenellenbogen; B A Stoica; M S McLemore; S E Olivo; A Stoica
Journal:  Endocrinology       Date:  2000-12       Impact factor: 4.736

2.  Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

Authors:  M Bartucci; C Morelli; L Mauro; S Andò; E Surmacz
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

3.  Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.

Authors:  Grégoire P Prévost; Marie O Lonchampt; Susan Holbeck; Samir Attoub; Daniel Zaharevitz; Mike Alley; John Wright; Marie C Brezak; Hélène Coulomb; Ann Savola; Marion Huchet; Sophie Chaumeron; Quang-Dé Nguyen; Patricia Forgez; Erik Bruyneel; Mark Bracke; Eric Ferrandis; Pierre Roubert; Danièle Demarquay; Christian Gespach; Philip G Kasprzyk
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

4.  Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway.

Authors:  Tommaso Simoncini; Camila Scorticati; Paolo Mannella; Ahmed Fadiel; Maria S Giretti; Xiao-Dong Fu; Chiara Baldacci; Silvia Garibaldi; Antonella Caruso; Letizia Fornari; Frederick Naftolin; Andrea R Genazzani
Journal:  Mol Endocrinol       Date:  2006-04-06

5.  Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.

Authors:  Rainer Girgert; Christian Bartsch; Steven M Hill; Rolf Kreienberg; Volker Hanf
Journal:  Neuro Endocrinol Lett       Date:  2003-12       Impact factor: 0.765

6.  Sphingosine kinase transmits estrogen signaling in human breast cancer cells.

Authors:  Olga A Sukocheva; Lijun Wang; Nathaniel Albanese; Stuart M Pitson; Mathew A Vadas; Pu Xia
Journal:  Mol Endocrinol       Date:  2003-07-24

7.  Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells.

Authors:  Victor E Nava; John Peyton Hobson; Shvetha Murthy; Sheldon Milstien; Sarah Spiegel
Journal:  Exp Cell Res       Date:  2002-11-15       Impact factor: 3.905

8.  Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin.

Authors:  Beatriz del Río; Juana M García Pedrero; Carlos Martínez-Campa; Pedro Zuazua; Pedro S Lazo; Sofía Ramos
Journal:  J Biol Chem       Date:  2004-06-30       Impact factor: 5.157

9.  MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.

Authors:  Lin Yuan; April R Collins; Jun Dai; Margarita L Dubocovich; Steven M Hill
Journal:  Mol Cell Endocrinol       Date:  2002-06-28       Impact factor: 4.102

10.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

View more
  9 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2012

Review 2.  Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Authors:  Marcela A Bennesch; Didier Picard
Journal:  Mol Endocrinol       Date:  2015-01-27

3.  Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.

Authors:  Bridgette M Collins-Burow; James W Antoon; Daniel E Frigo; Steven Elliott; Christopher B Weldon; Stephen M Boue; Barbara S Beckman; Tyler J Curiel; Jawed Alam; John A McLachlan; Matthew E Burow
Journal:  J Steroid Biochem Mol Biol       Date:  2012-05-24       Impact factor: 4.292

4.  MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.

Authors:  Suhail Ahmed Kabeer Rasheed; Cui Rong Teo; Emmanuel Jean Beillard; P Mathijs Voorhoeve; Wei Zhou; Sujoy Ghosh; Patrick J Casey
Journal:  Mol Cancer       Date:  2015-03-26       Impact factor: 27.401

5.  Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development.

Authors:  Hee Jin Son; Sung Hwa Sohn; Nayoung Kim; Ha-Na Lee; Sun Min Lee; Ryoung Hee Nam; Ji Hyun Park; Chin-Hee Song; Eun Shin; Hee Young Na; Joo Sung Kim; Dong Ho Lee; Young-Joon Surh
Journal:  Cancer Res Treat       Date:  2018-08-01       Impact factor: 4.679

6.  Estrogenic Activity of Mycoestrogen (3β,5α,22E)-Ergost-22-en-3-ol via Estrogen Receptor α-Dependent Signaling Pathways in MCF-7 Cells.

Authors:  Dahae Lee; Yuri Ko; Changhyun Pang; Yoon-Joo Ko; You-Kyoung Choi; Ki Hyun Kim; Ki Sung Kang
Journal:  Molecules       Date:  2021-12-22       Impact factor: 4.411

7.  Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance.

Authors:  James W Antoon; Rongye Lai; Amanda P Struckhoff; Ashley M Nitschke; Steven Elliott; Elizabeth C Martin; Lyndsay V Rhodes; Nam Seung Yoon; Virgilio A Salvo; Bin Shan; Barbara S Beckman; Kenneth P Nephew; Matthew E Burow
Journal:  Sci Rep       Date:  2012-07-27       Impact factor: 4.379

8.  Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.

Authors:  James W Antoon; Ashley M Nitzchke; Elizabeth C Martin; Lyndsay V Rhodes; Seungyoon Nam; Scott Wadsworth; Virgilo A Salvo; Steven Elliott; Bridgette Collins-Burow; Kenneth P Nephew; Matthew E Burow
Journal:  Int J Oncol       Date:  2013-02-08       Impact factor: 5.650

9.  Potential biological functions of microvesicles derived from adenoid cystic carcinoma.

Authors:  Zhuoyuan Zhang; Chaoran Yan; Bo Li; Longjiang Li
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.